Invesco Health Care R6 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Invesco Health Care Fund Class R6 GGHSX
- NAV / 1-Day Return 42.19 / +0.76 %
- Total Assets 1.2B
-
Adj. Expense Ratio
0.720%
- Expense Ratio 0.710%
- Distribution Fee Level Low
- Share Class Type Retirement, Large
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.00
- Turnover 59%
USD | NAV as of Jul 17, 2026 | 1-Day Return as of Jul 17, 2026, 12:11 AM GMT+0
Morningstar’s Analysis GGHSX
Will GGHSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 10.43 | 119M | Healthcare |
Johnson & Johnson | 6.04 | 69M | Healthcare |
UnitedHealth Group Inc | 5.73 | 65M | Healthcare |
Gilead Sciences Inc | 3.97 | 45M | Healthcare |
argenx SE ADR | 3.88 | 44M | Healthcare |
AbbVie Inc | 3.69 | 42M | Healthcare |
Merck & Co Inc | 3.38 | 39M | Healthcare |
AstraZeneca PLC | 3.37 | 38M | Healthcare |
BrightSpring Health Services Inc | 2.60 | 30M | Healthcare |
McKesson Corp | 2.60 | 30M | Healthcare |
United States